The growing adoption of GLP-1 medications has already begun to transform society and industry sectors, along with helping many patients effectively deal with managing diabetes and obesity, and other conditions.…
What You Should Know Lucent Diagnostics (a brand of Quanterix) and Tempus AI have announced a strategic collaboration to integrate Alzheimer’s blood-based biomarker testing into routine clinical workflows. The LucentAD®…
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
What You Should Know New Withings report, The Menopause Transition 2026 analyzes real-world data from 2.5 million women across 11 countries to identify physiological shifts during the transition. Atrial Fibrillation…
Healthcare cybersecurity is no longer just a technical discipline handled by IT teams. That view has changed. Cybersecurity in healthcare has grown. It now sits at the intersection of operations,…
Recent hantavirus cases among cruise travelers have put this rare but serious virus back on the radar. The overall risk of catching it remains low, but knowing the early warning…
GLP-1 medicines are widely used to manage diabetes and support weight loss. Now, researchers are also exploring how these drugs may affect brain health. Scientists are asking an important question:…
The Trump administration is seeking unprecedented access to medical records of federal workers and retirees, and their families. The data could be used to implement cost-saving measures, but it would…
Single-payer healthcare is a central talking point in the chaotic race for California governor. In a crowded field, top-polling Democrats are declaring their support for a government-run health system but…